Swift, M. D., Breeher, L. E., Tande, A. J., Tommaso, C. P., Hainy, C. M., Chu, H., . . . Virk, A. (2021). Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel. Clinical infectious diseases, 73(6), e1376. https://doi.org/10.1093/cid/ciab361
Chicago Style (17th ed.) CitationSwift, Melanie D., Laura E. Breeher, Aaron J. Tande, Christopher P. Tommaso, Caitlin M. Hainy, Haitao Chu, M Hassan Murad, Elie F. Berbari, and Abinash Virk. "Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel." Clinical Infectious Diseases 73, no. 6 (2021): e1376. https://doi.org/10.1093/cid/ciab361.
MLA (9th ed.) CitationSwift, Melanie D., et al. "Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel." Clinical Infectious Diseases, vol. 73, no. 6, 2021, p. e1376, https://doi.org/10.1093/cid/ciab361.